These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Induction of CD8(+) T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine. Pearson FE; O'Mahony C; Moore AC; Hill AV Vaccine; 2015 Jun; 33(28):3248-55. PubMed ID: 25839104 [TBL] [Abstract][Full Text] [Related]
4. Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacterium. de Groot AM; Du G; Mönkäre J; Platteel ACM; Broere F; Bouwstra JA; Sijts AJAM J Control Release; 2017 Nov; 266():27-35. PubMed ID: 28917531 [TBL] [Abstract][Full Text] [Related]
5. Skin vaccination with live virus vectored microneedle arrays induce long lived CD8(+) T cell memory. Becker PD; Hervouet C; Mason GM; Kwon SY; Klavinskis LS Vaccine; 2015 Sep; 33(37):4691-8. PubMed ID: 25917679 [TBL] [Abstract][Full Text] [Related]
6. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response. Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036 [TBL] [Abstract][Full Text] [Related]
11. Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice. Carey JB; Pearson FE; Vrdoljak A; McGrath MG; Crean AM; Walsh PT; Doody T; O'Mahony C; Hill AV; Moore AC PLoS One; 2011; 6(7):e22442. PubMed ID: 21799855 [TBL] [Abstract][Full Text] [Related]
12. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules. Sexton A; Whitney PG; Chong SF; Zelikin AN; Johnston AP; De Rose R; Brooks AG; Caruso F; Kent SJ ACS Nano; 2009 Nov; 3(11):3391-400. PubMed ID: 19824668 [TBL] [Abstract][Full Text] [Related]
13. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity. Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514 [TBL] [Abstract][Full Text] [Related]
14. Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. Zaric M; Lyubomska O; Touzelet O; Poux C; Al-Zahrani S; Fay F; Wallace L; Terhorst D; Malissen B; Henri S; Power UF; Scott CJ; Donnelly RF; Kissenpfennig A ACS Nano; 2013 Mar; 7(3):2042-55. PubMed ID: 23373658 [TBL] [Abstract][Full Text] [Related]
15. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design. Chen MC; Lai KY; Ling MH; Lin CW Acta Biomater; 2018 Jan; 65():66-75. PubMed ID: 29109028 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment. Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025 [TBL] [Abstract][Full Text] [Related]